Pamorelin Powder for Suspension for Injection 22.5 mg per vial
Product details
Registration number: SIN14325P
Classification: Prescription Only
Active ingredients: Triptorelin Embonate 31 mg eqv Triptorelin
Strength: 22.5 mg
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
Route: INTRAMUSCULAR
Registrant: ORIENT EUROPHARMA PTE LTD
ATC code: L02AE04
HSA approval date: 11 March 2013
Manufacturer(s):
- Debiopharm Research & Manufacturing SA
- Synergy Health Daniken AG (Contract Sterilization Facility)
Manufacturing country/countries: SWITZERLAND
What are the HSA registration number and classification for Pamorelin Powder for Suspension for Injection 22.5 mg per vial?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN14325P
Classification: Prescription Only
What active ingredients and strength are recorded for Pamorelin Powder for Suspension for Injection 22.5 mg per vial?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Triptorelin Embonate 31 mg eqv Triptorelin
Strength: 22.5 mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for Pamorelin Powder for Suspension for Injection 22.5 mg per vial?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
Route: INTRAMUSCULAR
Who is the recorded registrant for Pamorelin Powder for Suspension for Injection 22.5 mg per vial?
According to the HSA dataset updated 7 August 2026:
Registrant: ORIENT EUROPHARMA PTE LTD
Which manufacturers and countries are listed for Pamorelin Powder for Suspension for Injection 22.5 mg per vial?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Debiopharm Research & Manufacturing SA
- Synergy Health Daniken AG (Contract Sterilization Facility)
Manufacturing country/countries: SWITZERLAND
Where can I look up Pamorelin Powder for Suspension for Injection 22.5 mg per vial in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN14325P or the exact product name Pamorelin Powder for Suspension for Injection 22.5 mg per vial. The general register link does not preselect this product.
What are the source dates for this Pamorelin Powder for Suspension for Injection 22.5 mg per vial record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this Pamorelin Powder for Suspension for Injection 22.5 mg per vial record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN14325P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)